Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.
7 trends tracked about this subject — the full history, oldest to newest below.
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Food safety has emerged as a central election issue following a series of major outbreaks and recalls that are driving consumer concern across the U.S.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The FDA has authorized the use of bemotrizinol, the first new sunscreen ingredient approved for the U.S. market in two decades.
After two decades of stagnation, the FDA has approved a new sunscreen ingredient—one already widely used abroad.